ANKRD33
protein-codingankyrin repeat domain 33, the group of Ankyrin repeat domain containing
Gene summary
Predicted to act upstream of or within negative regulation of transcription by RNA polymerase II and skeletal muscle cell differentiation. Predicted to be located in cytosol and nucleus. [provided by Alliance of Genome Resources, Jun 2026]
- C12orf7
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~3.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ANKRD33 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_182608.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 3 | 4 | |||
| missense | 62 | 1 | 63 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 63 | 4 | 0 | 67 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_872414.3 | 5 | MANE Select | |
| Ensembl | ENSP00000301190.6 | 5 | MANE Select | |
| RefSeq | NP_001123487.1 | 4 | Standard | |
| RefSeq | NP_001291388.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- negative regulation of transcription by RNA polymerase II
- skeletal muscle cell differentiation
- negative regulation of transcription regulatory region DNA binding
Cellular Component
- nucleus
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000301190
- Coding exons
- 5
- Length
- 3705
- Individuals with no LoFs
- 125561
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 186
- Defined
- 125748
- p
- 0.000744
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.336 | 258 | 274 | 0.943 | 0.0000159 | 2874 |
| Missense (PolyPhen) | 92 | 102.96 | 0.89358 | 1070 | ||
| Synonymous | -0.186 | 121 | 118 | 1.02 | 0.00000716 | 977 |
| Loss of Function | -1.49 | 22 | 15.6 | 1.41 | 8.55e-7 | 148 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.0010 | 0.00099 | rare |
| East Asian | 0.0015 | 0.0015 | notable |
| Finnish | 0.00011 | 0.000092 | rare |
| European (Non-Finnish) | 0.00023 | 0.00022 | rare |
| South Asian | 0.0037 | 0.0037 | notable |
| Other | 0.00066 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acts as a transcriptional repressor for CRX-activated photoreceptor gene regulation. {ECO:0000250|UniProtKB:Q8BXP5}.;
Intolerance Scores
- LoFtool
- 0.917
- RVIS EVS
- 1.11
- RVIS percentile EVS
- 92.07
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.122
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |